<DOC>
	<DOC>NCT02653703</DOC>
	<brief_summary>The aim of this study is to quantitatively characterize the effects of L-menthol as a topical counter-irritant on cutaneous pain and hyperalgesia provoked by topical application of the TRPA1-agonist trans-cinnamaldehyde (CA) in healthy human volunteers.</brief_summary>
	<brief_title>L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain</brief_title>
	<detailed_description>This study is designed as an experimental model in healthy humans.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Neurogenic Inflammation</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Cinnamic aldehyde</mesh_term>
	<criteria>18 healthy men and women aged 1850 years willing to abstain from alcohol, nicotine, caffeine and pain medication 24 hours before experimental sessions Pregnancy Skin disorders (e.g. contact eczema) Chronic pain conditions Drug addiction defined as the use of cannabis, opioids or other drugs Previous neurologic, musculoskeletal or mental illnesses Lack of ability to cooperate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>